• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

提高臀肌内注射的成功率。

Improving the success rate of gluteal intramuscular injections.

机构信息

Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

出版信息

Pancreas. 2013 Jul;42(5):878-82. doi: 10.1097/MPA.0b013e318279d552.

DOI:10.1097/MPA.0b013e318279d552
PMID:23508015
Abstract

OBJECTIVES

This study aimed to improve the success rate of gluteal intramuscular (IM) injection.

METHODS

The outcomes of 328 intended gluteal IM injections in 115 patients receiving depot octreotide were evaluated using computed tomography performed in routine clinical practice. Patient-, nursing-, and technique-dependent factors were correlated with successful delivery of medication. Techniques associated with successful injection were taught to center nurses.

RESULTS

At baseline, 52% of injections were successfully delivered (66% men, 36% women; P = 0.001). Factors associated with successful delivery included nurses' frequency of injections (P = 0.008), landmarks use to select injection site (P < 0.001), quick needle insertion (P < 0.001), and use of nonsyringe hand to compress injection site (P < 0.001). Patient-related factors included male sex (P < 0.001), lower body mass index (P < 0.001), and lower skin-to-muscle depth at injection site (P < 0.001). Techniques associated with successful injections were then taught to center nurses. After instruction, the success rate increased from 52% to 75% (P = 0.001). Importantly, improvements were observed in both men (66%-75%; P = 0.43) and women (38%-75%; P < 0.001). Successful injection was associated with better control of flushing among those with carcinoid syndrome (P = 0.005).

CONCLUSIONS

Intended gluteal IM injections often are given into the subcutaneous space. Education in techniques associated with successful injections improves IM delivery rates.

摘要

目的

本研究旨在提高臀肌肌内(IM)注射的成功率。

方法

在常规临床实践中使用计算机断层扫描评估了 115 名接受奥曲肽储库注射的患者的 328 次预期臀肌 IM 注射的结果。将与药物输送成功相关的患者、护理和技术相关因素进行了相关性分析。将与成功注射相关的技术教授给中心护士。

结果

基线时,52%的注射成功(66%为男性,36%为女性;P=0.001)。与成功注射相关的因素包括护士的注射频率(P=0.008)、选择注射部位的标志(P<0.001)、快速进针(P<0.001)和使用非注射器手按压注射部位(P<0.001)。患者相关因素包括男性(P<0.001)、较低的体重指数(P<0.001)和注射部位皮肤-肌肉深度较低(P<0.001)。然后将与成功注射相关的技术教授给中心护士。在指导之后,成功率从 52%提高到 75%(P=0.001)。重要的是,男性(66%-75%;P=0.43)和女性(38%-75%;P<0.001)均观察到了改善。在类癌综合征患者中,成功注射与更好地控制潮红有关(P=0.005)。

结论

预期的臀肌 IM 注射通常注入皮下空间。与成功注射相关的技术教育可提高 IM 输送率。

相似文献

1
Improving the success rate of gluteal intramuscular injections.提高臀肌内注射的成功率。
Pancreas. 2013 Jul;42(5):878-82. doi: 10.1097/MPA.0b013e318279d552.
2
Body Mass Index: A Reliable Predictor of Subcutaneous Fat Thickness and Needle Length for Ventral Gluteal Intramuscular Injections.体重指数:预测臀肌腹内注射中皮下脂肪厚度和针头长度的可靠指标。
Am J Ther. 2019 Jan/Feb;26(1):e72-e78. doi: 10.1097/MJT.0000000000000474.
3
Influence of gender, BMI and body shape on theoretical injection outcome at the ventrogluteal and dorsogluteal sites.性别、BMI 和体型对臀外侧和臀上部注射部位理论注射效果的影响。
J Clin Nurs. 2018 Jan;27(1-2):e242-e250. doi: 10.1111/jocn.13923. Epub 2017 Nov 20.
4
Intramuscular injections into the buttocks: are they truly intramuscular?臀部肌肉注射:它们真的是注入肌肉内吗?
Eur J Radiol. 2006 Jun;58(3):480-4. doi: 10.1016/j.ejrad.2006.01.008. Epub 2006 Feb 21.
5
Computed tomographic measurement of gluteal subcutaneous fat thickness in reference to failure of gluteal intramuscular injections.基于臀肌肌内注射失败的计算机断层扫描测量臀肌皮下脂肪厚度
Can Assoc Radiol J. 2007 Apr;58(2):72-5.
6
[Gluteal subcutaneous fat thickness measured by computed tomography as an estimate of proper gluteal intramuscular injections in Korean adults].[通过计算机断层扫描测量臀皮下脂肪厚度以评估韩国成年人合适的臀肌内注射情况]
J Korean Acad Nurs. 2010 Apr;40(2):247-54. doi: 10.4040/jkan.2010.40.2.247.
7
Intended intramuscular gluteal injections: are they truly intramuscular?预期的臀肌肌内注射:它们真的是注入肌肉内吗?
J Postgrad Med. 2014 Apr-Jun;60(2):175-8. doi: 10.4103/0022-3859.132334.
8
Intramuscular injections in children.
Pediatrics. 1982 Dec;70(6):944-8.
9
Are IM injections IM in obese and overweight females? A study in injection technique.肌内注射在肥胖和超重女性中是否可行?一项关于注射技术的研究。
Appl Nurs Res. 2013 Nov;26(4):e1-4. doi: 10.1016/j.apnr.2013.09.002. Epub 2013 Sep 30.
10
The thigh may not be suitable as an injection site for patients self-injecting sumatriptan.对于自行注射舒马曲坦的患者,大腿可能不是合适的注射部位。
Neurology. 1997 Aug;49(2):559-61. doi: 10.1212/wnl.49.2.559.

引用本文的文献

1
A Randomized Phase 1 Study Evaluating Pharmacokinetics, Safety, and Tolerability of a High-Concentration, Long-Acting Cabotegravir Formulation in Adults Without HIV.一项评估高浓度长效卡博特韦制剂在未感染艾滋病毒成人中的药代动力学、安全性和耐受性的随机1期研究。
Clin Pharmacol Drug Dev. 2025 Jul;14(7):528-541. doi: 10.1002/cpdd.1538. Epub 2025 Apr 29.
2
Oral paltusotine, a nonpeptide selective somatostatin receptor 2 agonist: Mass balance, absolute bioavailability and metabolism in healthy participants.口服帕托索汀,一种非肽类选择性生长抑素受体2激动剂:健康受试者的质量平衡、绝对生物利用度和代谢
Br J Clin Pharmacol. 2025 Jul;91(7):2070-2079. doi: 10.1002/bcp.70020. Epub 2025 Mar 5.
3
Population pharmacokinetics of cabotegravir following intramuscular thigh injections in adults with and without HIV.
在有和没有感染艾滋病毒的成年人中,经大腿肌肉注射后卡博特韦的群体药代动力学。
Antimicrob Agents Chemother. 2024 Dec 5;68(12):e0088024. doi: 10.1128/aac.00880-24. Epub 2024 Oct 23.
4
Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine.从注射用生长抑素受体配体转换为口服帕妥索汀后肢端肥大症病情得到控制
J Clin Endocrinol Metab. 2024 Dec 18;110(1):228-237. doi: 10.1210/clinem/dgae385.
5
Adverse effects of dorsogluteal intramuscular injection versus ventrogluteal intramuscular injection: A systematic review and meta-analysis.臀肌外侧与臀肌前侧肌内注射的不良反应:系统评价与荟萃分析。
Nurs Open. 2023 Sep;10(9):5975-5988. doi: 10.1002/nop2.1902. Epub 2023 Jul 14.
6
Gluteal muscle and subcutaneous tissue thicknesses in adults: a systematic review and meta-analysis.成人臀肌和皮下组织厚度:一项系统评价和荟萃分析。
J Res Nurs. 2023 May;28(3):181-196. doi: 10.1177/17449871231155769. Epub 2023 Apr 30.
7
Discovery of Paltusotine (CRN00808), a Potent, Selective, and Orally Bioavailable Non-peptide SST2 Agonist.帕图索汀(CRN00808)的发现,一种强效、选择性且口服生物可利用的非肽类SST2激动剂。
ACS Med Chem Lett. 2022 Dec 10;14(1):66-74. doi: 10.1021/acsmedchemlett.2c00431. eCollection 2023 Jan 12.
8
ACROBAT Edge: Safety and Efficacy of Switching Injected SRLs to Oral Paltusotine in Patients With Acromegaly.ACROBAT Edge:将注射用 SRL 转换为口服培特索坦治疗肢端肥大症患者的安全性和疗效。
J Clin Endocrinol Metab. 2023 Apr 13;108(5):e148-e159. doi: 10.1210/clinem/dgac643.
9
Somatostatin receptors in congenital hyperinsulinism: Biology to bedside.先天性高胰岛素血症中的生长抑素受体:从基础生物学到临床。
Front Endocrinol (Lausanne). 2022 Sep 27;13:921357. doi: 10.3389/fendo.2022.921357. eCollection 2022.
10
Population pharmacokinetics of cabotegravir following administration of oral tablet and long-acting intramuscular injection in adult HIV-1-infected and uninfected subjects.成人 HIV-1 感染者和未感染者经口片剂和长效肌内注射给予卡博替拉韦后的群体药代动力学。
Br J Clin Pharmacol. 2022 Oct;88(10):4607-4622. doi: 10.1111/bcp.15439. Epub 2022 Jul 4.